Original Chemical Series of Pyrimidine Biosynthesis Inhibitors That Boost the Antiviral Interferon Response.

about

Original Chemical Series of Pyrimidine Biosynthesis Inhibitors That Boost the Antiviral Interferon Response.

Item

http://www.wikidata.org/entity/Q40083234

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Original Chemical Series of Py ...... Antiviral Interferon Response.

@en

type

Item

label

Original Chemical Series of Py ...... Antiviral Interferon Response.

@en

prefLabel

Original Chemical Series of Py ...... Antiviral Interferon Response.

@en

P1476

Original Chemical Series of Py ...... Antiviral Interferon Response.

@en

P2093

Daniel Dauzonne

http://www.w3.org/2001/XMLSchema#string

Julien Dairou

http://www.w3.org/2001/XMLSchema#string

Marianne Lucas-Hourani

http://www.w3.org/2001/XMLSchema#string

Olivier Helynck

http://www.w3.org/2001/XMLSchema#string

Samira Khiar

http://www.w3.org/2001/XMLSchema#string

P2860

Comparative analysis of viral RNA signatures on different RIG-I-like receptors

The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, mda-5, and inhibit its activation of the IFN-beta promoter

Structures of human dihydroorotate dehydrogenase in complex with antiproliferative agents

Inhibition of human DHODH by 4-hydroxycoumarins, fenamic acids, and N-(alkylcarbonyl)anthranilic acids identified by structure-guided fragment selection

Paramyxovirus V proteins disrupt the fold of the RNA sensor MDA5 to inhibit antiviral signaling

On dihydroorotate dehydrogenases and their inhibitors and uses

Inhibition of pyrimidine biosynthesis pathway suppresses viral growth through innate immunity

A human coronavirus responsible for the common cold massively kills dendritic cells but not monocytes

D282, a non-nucleoside inhibitor of influenza virus infection that interferes with de novo pyrimidine biosynthesis.

Parallel shRNA and CRISPR-Cas9 screens enable antiviral drug target identification.

P31

scholarly article

P356

10.1128/AAC.00383-17

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Hélène Munier-Lehmann

Philippe V Afonso

Sébastien Nisole

Pierre-Olivier Vidalain

Frédéric Tangy

P577

2017-08-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28807907

http://www.w3.org/2001/XMLSchema#string

P932

5610480

http://www.w3.org/2001/XMLSchema#string